Bibliographic citations
Villavicencio, E., (2021). Digestibilidad de Zea mays "Maíz Chala" y hoja de Musa paradisiaca L. "plátano" y su efecto en el rendimiento productivo de Cavia porcellus [Universidad Nacional de Trujillo]. https://hdl.handle.net/20.500.14414/19360
Villavicencio, E., Digestibilidad de Zea mays "Maíz Chala" y hoja de Musa paradisiaca L. "plátano" y su efecto en el rendimiento productivo de Cavia porcellus []. PE: Universidad Nacional de Trujillo; 2021. https://hdl.handle.net/20.500.14414/19360
@misc{renati/1049201,
title = "Digestibilidad de Zea mays "Maíz Chala" y hoja de Musa paradisiaca L. "plátano" y su efecto en el rendimiento productivo de Cavia porcellus",
author = "Villavicencio Alvarez, Estefany",
publisher = "Universidad Nacional de Trujillo",
year = "2021"
}
ABSTRACT The digestibility of Zea mays "Maíz Chala" and Musa paradisiaca L. "plantain" leaf and their effect on the productive performance of Cavia porcellus were evaluated. The study comprised two stages: digestibility in Lima and productive performance in Chepén. In the first stage, the treatments were T0: 100% corn husk, T1: 50% corn husk + 50% banana leaf, and T2: 100% banana leaf, the animals being randomly distributed in a DCA. The digestibility coefficients for T0 were: DM.: 67.35%, OM: 68.04%, CP: 57.23%, CF: 76.68%, Ash: 58.64%, T1 DM.: 46.07%, OM.: 46.57%, CP: 45.76%, CF.: 68.26%, Ashes: 41.68%, and for T2 DM: 20.29%, OM.: 21.96%, CP: 39.28%, CF: 57.20%, Ashes: 15.60% respectively. In the second stage the treatments were the same, adding concentrate to each treatment. The average gain animal-1.day-1 was 12.78 g, 11.75 g, 11.34 g and the C.A. was: 8.4, 7.8 and 7.8 for T0, T1 and T2 respectively. Significant statistical differences were observed between the means of the treatments T0 and T2 (p <0.05) for MS., MO., PB, Ash and TUKEY was used as a statistical test. It is concluded that the highest digestibility, greater weight gain and lower mortality were obtained in the T0 treatment and the best food conversions in the T1 and T2 treatments.
This item is licensed under a Creative Commons License